SKBA Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
SKBA Capital Management's GILD Position: Q4 2020 in Review
SKBA Capital Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 108,400 shares — an estimated $6.85M sold.
SKBA Capital Management first reported a position in GILD in Q1 2015 and held it in 22 quarters. The position peaked at $15.3M in Q3 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- SKBA Capital Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- SKBA Capital Management sold 108,400 Gilead Sciences shares in Q4 2020, an estimated $6.85M.
- SKBA Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 22 quarters.
- SKBA Capital Management's Gilead Sciences position peaked at $15.3M in Q3 2018.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on SKBA Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.